Role of alpha 2-plasmin inhibitor in the appearance of fibrinolytic activity during urokinase administration, and an evaluation of the optimal urokinase dosage.
D004305:Dose-Response Relationship, Drug; D010450:Endopeptidases / Q000008:administration & dosage*; D005337:Fibrin / Q000494:pharmacology; D005340:Fibrinogen; D005342:Fibrinolysis; D006801:Humans; D010958:Plasminogen; D014568:Urokinase-Type Plasminogen Activator / Q000008:administration & dosage*; D000515:alpha 1-Antitrypsin; D000979:alpha-2-Antiplasmin; D000511:alpha-Macroglobulins
D000515:alpha 1-Antitrypsin; D000979:alpha-2-Antiplasmin; D000511:alpha-Macroglobulins; D005337:Fibrin; D005340:Fibrinogen; D010958:Plasminogen; D010450:Endopeptidases; D014568:Urokinase-Type Plasminogen Activator